RxDoctor Payments Data

Patrick Lo, DO

Family Medicine · Okc, OKNPI 1295742039

Payments from drug & device makers

$3,081in general payments, 2019–2025

Across 176 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$407
  • Novo Nordisk$360
  • Boehringer Ingelheim$335
  • AstraZeneca$300
  • GSK$270
  • Amarin Pharma, Inc.$236
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,87193%
  • Education$1926%
  • Gifts$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,081 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$43,002
Medicare patients
125
Services billed
1,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin157$176,331
JanuviaSitagliptin Phosphate85$105,995
EliquisApixaban84$69,944
Spiriva RespimatTiotropium Bromide125$68,627
GlyxambiEmpagliflozin/Linagliptin63$62,750
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$56,170
TradjentaLinagliptin53$55,151
OzempicSemaglutide43$41,462
FarxigaDapagliflozin Propanediol36$40,928
RybelsusSemaglutide27$34,064
VascepaIcosapent Ethyl30$25,269
TrulicityDulaglutide15$20,699
XareltoRivaroxaban28$19,676
ProliaDenosumab11$19,392
MyrbetriqMirabegron18$17,769

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Glyxambi, Tradjenta$335$362,859398 claims
MerckJanuvia, Janumet Xr, Janumet$190$133,755114 claims
Novo NordiskOzempic, Rybelsus$360$75,52670 claims
PfizerEliquis$407$69,94484 claims
GSKTrelegy Ellipta, Breo Ellipta$270$64,89085 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$300$63,27861 claims
Lilly USA, LLCTrulicity$73$20,69915 claims
Johnson & JohnsonXarelto$97$19,67628 claims
AmgenProlia$54$19,39211 claims
Astellas Pharma US IncMyrbetriq$180$17,76918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Okc

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →